{"component": "definition", "props": {"groups": [{"samples": [{"hash": "7zC2IbYiKNk", "uri": "https://www.sec.gov/Archives/edgar/data/792977/000079297718000073/ex107.htm", "label": "Distribution and Supply Agreement (Amag Pharmaceuticals Inc.)", "score": 17.9691982269, "published": false}, {"hash": "lD0PDTAoXCI", "uri": "https://www.sec.gov/Archives/edgar/data/792977/000079297718000053/ex107.htm", "label": "Distribution and Supply Agreement (Amag Pharmaceuticals Inc.)", "score": 17.585899353, "published": false}, {"hash": "aLnDWolhatj", "uri": "http://ir.amagpharma.com/static-files/59e7c5d7-4068-4ce4-ad3b-3f97ed2ec605", "label": "Amendment", "score": 14.1704311371, "published": false}], "size": 5, "snippet_links": [{"key": "single-dose", "type": "definition", "offset": [99, 110]}, {"key": "single-unit", "type": "clause", "offset": [127, 138]}], "snippet": "means a hydroxyprogesterone caproate injection supplied in (i) 250 mg/mL preservative free in 1 mL single dose glass vial in a single unit carton bundled with four in each tray or pack, and (ii) 250 mg/mL in 5 mL multidose glass vial in a single unit carton, each in Manufactured form and sold under AMAG\u2019s NDA.", "hash": "916a35cabb6c9ce7519f6a1ffc49de44", "id": 1}, {"samples": [{"hash": "bitxEGzSBf0", "uri": "/contracts/bitxEGzSBf0#ag-product", "label": "Settlement Agreement", "score": 31.3408622742, "published": true}, {"hash": "gTOv9SH2T65", "uri": "/contracts/gTOv9SH2T65#ag-product", "label": "Settlement Agreement (Supernus Pharmaceuticals Inc)", "score": 28.3511295319, "published": true}, {"hash": "2Axuw6LXGGr", "uri": "/contracts/2Axuw6LXGGr#ag-product", "label": "Settlement Agreement (Supernus Pharmaceuticals Inc)", "score": 28.3511295319, "published": true}], "size": 5, "snippet_links": [{"key": "active-ingredient", "type": "definition", "offset": [104, 121]}, {"key": "supernus-nda", "type": "definition", "offset": [161, 173]}], "snippet": "means a product that is not Labeled with the Trokendi XR\u00ae trademark containing the Compound as its sole active ingredient that is Marketed or supplied under the Supernus NDA, described therein now or hereafter.", "hash": "045cce429b1c6a0b18c3904b8d6a895b", "id": 2}, {"samples": [{"hash": "aIMEoYtyTyo", "uri": "/contracts/aIMEoYtyTyo#ag-product", "label": "Supply and Distribution Agreement", "score": 31.3408622742, "published": true}, {"hash": "7wNCCHF46bz", "uri": "/contracts/7wNCCHF46bz#ag-product", "label": "Supply and Distribution Agreement (Eagle Pharmaceuticals, Inc.)", "score": 24.9671459198, "published": true}, {"hash": "4BelPmJfX4r", "uri": "/contracts/4BelPmJfX4r#ag-product", "label": "Supply and Distribution Agreement (Eagle Pharmaceuticals, Inc.)", "score": 24.9589328766, "published": true}], "size": 4, "snippet_links": [{"key": "form-of", "type": "definition", "offset": [29, 36]}, {"key": "branded-product", "type": "definition", "offset": [47, 62]}, {"key": "schedule-a", "type": "clause", "offset": [79, 89]}], "snippet": "means an unbranded (generic) form of the Eagle Branded Product as described on Schedule A distributed exclusively by Sandoz under a label not referencing the Eagle Trademark.", "hash": "7c8696094810eb21b3d5dc6fa844bfc4", "id": 3}, {"samples": [{"hash": "90bMd5gvm2h", "uri": "/contracts/90bMd5gvm2h#ag-product", "label": "Settlement Agreement (Supernus Pharmaceuticals, Inc.)", "score": 35.5954818726, "published": true}, {"hash": "2cA6Fshj2yV", "uri": "https://ir.supernus.com/static-files/0f7057e4-20ad-4bbd-9605-b6548347e719", "label": "ir.supernus.com", "score": 16.4387073517, "published": false}], "size": 4, "snippet_links": [{"key": "active-ingredient", "type": "definition", "offset": [120, 137]}, {"key": "supernus-nda", "type": "definition", "offset": [177, 189]}], "snippet": "means a product that is not Labeled with the Trokendi XR\u00ae trademark containing the Compound in any strength as its sole active ingredient that is Marketed or supplied under the Supernus NDA, described therein now or hereafter.", "hash": "99653b030956e95d6d5a01cba6604733", "id": 4}, {"samples": [{"hash": "gYaPF45qLmY", "uri": "/contracts/gYaPF45qLmY#ag-product", "label": "License and Commercial Supply Agreement (Intellipharmaceutics International Inc.)", "score": 31.2423000336, "published": true}, {"hash": "dnhRBm565Pk", "uri": "/contracts/dnhRBm565Pk#ag-product", "label": "License and Commercial Supply Agreement (Intellipharmaceutics International Inc.)", "score": 31.2423000336, "published": true}, {"hash": "1xwzqMjKfvl", "uri": "/contracts/1xwzqMjKfvl#ag-product", "label": "License and Commercial Supply Agreement (Intellipharmaceutics International Inc.)", "score": 31.2423000336, "published": true}], "size": 3, "snippet_links": [{"key": "innovator-product", "type": "definition", "offset": [34, 51]}, {"key": "offered-for-sale", "type": "definition", "offset": [86, 102]}, {"key": "generic-product", "type": "definition", "offset": [143, 158]}, {"key": "pursuant-to-the", "type": "clause", "offset": [168, 183]}, {"key": "pharmaceutical-company", "type": "definition", "offset": [194, 216]}, {"key": "new-drug-application", "type": "definition", "offset": [228, 248]}, {"key": "the-fda", "type": "clause", "offset": [260, 267]}, {"key": "the-act", "type": "clause", "offset": [318, 325]}], "snippet": "means any product, other than the Innovator Product, promoted, distributed, marketed, offered for sale and/or sold as a branded or non-branded generic product under or pursuant to the Innovator Pharmaceutical Company\u2019s approved New Drug Application filed with the FDA pursuant to and under 21 U.S.C. Section 355(b) of the Act, for the Innovator Product.", "hash": "578150d931fc19df141217c3d22059a7", "id": 5}, {"samples": [{"hash": "6qIRb3IfYS4", "uri": "/contracts/6qIRb3IfYS4#ag-product", "label": "Settlement Agreement", "score": 31.3408622742, "published": true}, {"hash": "kxYRHCMfAwN", "uri": "/contracts/kxYRHCMfAwN#ag-product", "label": "Settlement Agreement (Barr Pharmaceuticals Inc)", "score": 21.0, "published": true}, {"hash": "8pAbOOWdvmK", "uri": "/contracts/8pAbOOWdvmK#ag-product", "label": "Settlement Agreement (Shire PLC)", "score": 21.0, "published": true}], "size": 3, "snippet_links": [{"key": "adderall-xr", "type": "definition", "offset": [56, 67]}], "snippet": "means Shire authorized and supplied generically Labeled Adderall XR.", "hash": "218908c98cd990f3f9782e238f45a3eb", "id": 6}, {"samples": [{"hash": "7OVexLeuO9Y", "uri": "/contracts/7OVexLeuO9Y#ag-product", "label": "Settlement and License Agreement", "score": 31.3408622742, "published": true}, {"hash": "eV6kImDBFF6", "uri": "/contracts/eV6kImDBFF6#ag-product", "label": "Settlement and License Agreement", "score": 24.1540050507, "published": true}, {"hash": "3RoHBa3zxJU", "uri": "/contracts/3RoHBa3zxJU#ag-product", "label": "Settlement and License Agreement (Endo Health Solutions Inc.)", "score": 23.4065704346, "published": true}], "size": 3, "snippet_links": [{"key": "generic-version", "type": "clause", "offset": [8, 23]}, {"key": "brand-product", "type": "definition", "offset": [31, 44]}, {"key": "product-nda", "type": "definition", "offset": [91, 102]}], "snippet": "means a generic version of the Brand Product that is manufactured and sold under the Brand Product NDA without a trademark or using a trademark other than Lidoderm\u00ae or a successor trademark thereto.", "hash": "f5879457e496a174296b01f21ef36af4", "id": 7}, {"samples": [{"hash": "bYet28wycMp", "uri": "/contracts/bYet28wycMp#ag-product", "label": "Development Services and Commercialization Agreement (IntelGenx Technologies Corp.)", "score": 25.5010261536, "published": true}, {"hash": "66zUIv2uS91", "uri": "/contracts/66zUIv2uS91#ag-product", "label": "Development Services and Commercialization Agreement (IntelGenx Technologies Corp.)", "score": 25.188911438, "published": true}, {"hash": "cBQKA5VqbAr", "uri": "https://www.annualreports.com/HostedData/AnnualReportArchive/i/TSX-V_IGX_2013.pdf", "label": "www.annualreports.com", "score": 7.094455719, "published": false}], "size": 3, "snippet_links": [{"key": "brand-product", "type": "definition", "offset": [43, 56]}, {"key": "for-sale", "type": "definition", "offset": [74, 82]}, {"key": "regulatory-approval", "type": "definition", "offset": [93, 112]}], "snippet": "means a generically labeled version of the Brand Product that is approved for sale under the Regulatory Approval for such Brand Product.", "hash": "b5a66c10ac5de70e1b0efdde30d73868", "id": 8}, {"samples": [{"hash": "6j0xx9w69F2", "uri": "/contracts/6j0xx9w69F2#ag-product", "label": "Development Services and Commercialization Agreement (IntelGenx Technologies Corp.)", "score": 25.5010261536, "published": true}, {"hash": "1h4HdU30YR1", "uri": "/contracts/1h4HdU30YR1#ag-product", "label": "Development Services and Commercialization Agreement (IntelGenx Technologies Corp.)", "score": 25.188911438, "published": true}], "size": 2, "snippet_links": [{"key": "brand-product", "type": "definition", "offset": [42, 55]}, {"key": "for-sale", "type": "definition", "offset": [73, 81]}, {"key": "regulatory-approval", "type": "definition", "offset": [92, 111]}], "snippet": "means a generically labelled version of a Brand Product that is approved for sale under the Regulatory Approval for such Brand Product.", "hash": "2aab030a9f9c8ea93a90d84c5f4921be", "id": 9}, {"samples": [{"hash": "d1YNIwV44W7", "uri": "/contracts/d1YNIwV44W7#ag-product", "label": "License and Distribution Agreement (Impax Laboratories Inc)", "score": 24.3347015381, "published": true}, {"hash": "5H6cVRgaQzE", "uri": "/contracts/5H6cVRgaQzE#ag-product", "label": "License and Distribution Agreement (Impax Laboratories Inc)", "score": 21.1533203125, "published": true}], "size": 2, "snippet_links": [{"key": "adderall-xr", "type": "definition", "offset": [26, 37]}, {"key": "commonly-called", "type": "clause", "offset": [39, 54]}, {"key": "authorized-generic-product", "type": "definition", "offset": [58, 84]}, {"key": "for-sale", "type": "definition", "offset": [95, 103]}, {"key": "the-fda", "type": "clause", "offset": [107, 114]}, {"key": "pursuant-to-a", "type": "definition", "offset": [115, 128]}, {"key": "supplement-to", "type": "clause", "offset": [138, 151]}], "snippet": "means generically Labeled Adderall XR, commonly called an authorized generic product, approved for sale by the FDA pursuant to a labeling supplement to Shire\u2019s NDA.", "hash": "e5a503d3a20b2a2dbbc4443ba835e839", "id": 10}], "next_curs": "ClcSUWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjMLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiITYWctcHJvZHVjdCMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"size": 47, "title": "AG Product", "snippet": "means a hydroxyprogesterone caproate injection supplied in (i) 250 mg/mL preservative free in 1 mL single dose glass vial in a single unit carton bundled with four in each tray or pack, and (ii) 250 mg/mL in 5 mL multidose glass vial in a single unit carton, each in Manufactured form and sold under AMAG\u2019s NDA.", "id": "ag-product", "examples": ["Deliveries of <strong>AG Product</strong> will be made in accordance with the delivery schedule set forth in the purchase orders provided, subject to Sections 4.3, 4.4 and 4.5.", "As such, Sandoz will provide Eagle with aggregate sales figures for the <strong>AG Product</strong> sales made by Sandoz and the related Net Profit split by product NDC number.", "Any deviations and investigations related to the <strong>AG Product</strong> will be documented by Eagle in accordance with the Eagle NDA and the Quality Agreement referred to in Section 6.1.", "Notwithstanding the foregoing, Eagle will have final authority for regulatory decisions and responsibility for all communications with FDA concerning the <strong>AG Product</strong>.", "To the extent there is an increase in Eagle\u2019s cost to acquire the <strong>AG Product</strong> as a result of an increase in API costs and filling costs at the Contract Manufacturer\u2019s facility (as evidenced by written records reasonably acceptable to Sandoz), in any case outside of the control of Eagle, the parties will agree to reasonable and equitable modifications in the Product Cost for the <strong>AG Product</strong> to reflect any increase in the manufacturing cost caused by such change.", "Sandoz will keep accurate books and records for purposes of documenting the amount of the Net Sales and product returns for <strong>AG Product</strong>.", "Thereafter, Sandoz will provide Eagle with a fifteen (15) month sales forecast beginning with January 1 of the following year and a monthly sales forecast for the remaining months of the Supply Term for the <strong>AG Product</strong> sixty (60) days before the end of each calendar year.", "Sandoz will not use any Promotional Materials in connection with the marketing, sale or distribution of the <strong>AG Product</strong> without Eagle\u2019s prior written approval, except that Sandoz may include such <strong>AG Product</strong>\u2019s generic name, launch date, available packaging configurations, and the pricing and delivery terms in its introduction announcements to the trade, \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 and product catalog without obtaining Eagle\u2019s prior written approval.", "Sandoz will have the responsibility in the Territory for complying with all regulatory requirements and other matters which relate solely to Sandoz\u2019s acting as a distributor of the <strong>AG Product</strong> in the Territory.", "If an <strong>AG Product</strong> accepted by Sandoz becomes non-conforming by virtue of the later discovery of a Latent Defect, Sandoz may place the lot on quality assurance hold pending Eagle\u2019s investigation and a final resolution of the claimed Latent Defect pursuant to Section 8.1 and 8.2 above."], "related": [["drug-product", "Drug Product", "Drug Product"], ["finished-product", "Finished Product", "Finished Product"], ["aerosol-product", "Aerosol Product", "Aerosol Product"], ["hemp-product", "Hemp product", "Hemp product"], ["product", "Product", "Product"]], "related_snippets": [], "updated": "2026-02-25T05:25:33+00:00"}, "json": true, "cursor": ""}}